MVGclinic: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MVGclinic
Largest movements
- Tangible fixed assets +€695,394
up €695,394 (+51.5%), from €1.4m to €2.0m
of which Land and buildings: +€1.2m
- Other debts +€509,084
up €509,084 (+69.7%), from €730,206 to €1.2m
- Debts after one year +€197,356
up €197,356 (+23.2%), from €850,467 to €1.0m
- Profit (loss) carried forward -€84,659
down €84,659 (-32.5%), from -€260,191 to -€344,850
- Current portion of long-term debt +€45,678
up €45,678 (+73.4%), from €62,202 to €107,880
- Gross operating margin +€72,611
up €72,611, from -€53,668 to €18,943
- Financial charges +€27,372
up €27,372 (+88.1%), from €31,057 to €58,429
- Depreciation +€24,421
up €24,421 (+143%), from €17,113 to €41,534
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,419,858 | €2,123,900 | +€704,041 | +49.6% |
| Fixed assets | 21/28 | €1,351,652 | €2,047,046 | +€695,394 | +51.4% |
| Tangible fixed assets | 22/27 | €1,351,476 | €2,046,870 | +€695,394 | +51.5% |
| Land and buildings | 22 | €613,221 | €1,788,427 | +€1.2m | +192% |
| Plant, machinery and equipment | 23 | €5,057 | €258,443 | +€253,387 | +5,011% |
| Assets under construction and advance payments | 27 | €733,198 | €0 | -€733,198 | -100% |
| Financial fixed assets | 28 | €176 | €176 | = | 0.0% |
| Current assets | 29/58 | €68,206 | €76,853 | +€8,647 | +12.7% |
| Amounts receivable within one year | 40/41 | €34,180 | €52,482 | +€18,301 | +53.5% |
| Trade receivables | 40 | €16,567 | €52,459 | +€35,892 | +217% |
| Other amounts receivable | 41 | €17,613 | €22 | -€17,591 | -99.9% |
| Cash at bank and in hand | 54/58 | €34,026 | €24,372 | -€9,654 | -28.4% |
| Total equity and liabilities | 10/49 | €1,419,858 | €2,123,900 | +€704,041 | +49.6% |
| Equity | 10/15 | -€235,191 | -€319,850 | -€84,659 | -36.0% |
| Contributions | 10/11 | €25,000 | €25,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€260,191 | -€344,850 | -€84,659 | -32.5% |
| Amounts payable | 17/49 | €1,655,049 | €2,443,750 | +€788,700 | +47.7% |
| Amounts payable after more than one year | 17 | €850,467 | €1,047,823 | +€197,356 | +23.2% |
| Financial debts | 170/4 | €850,467 | €1,047,823 | +€197,356 | +23.2% |
| Amounts payable within one year | 42/48 | €792,408 | €1,371,856 | +€579,448 | +73.1% |
| Current portion of amounts payable after more than one year | 42 | €62,202 | €107,880 | +€45,678 | +73.4% |
| Trade debts | 44 | €0 | €9,377 | +€9,377 | |
| Suppliers | 440/4 | €0 | €9,377 | +€9,377 | |
| Advances received on contracts in progress | 46 | - | €12,705 | +€12,705 | |
| Taxes, remuneration and social security | 45 | - | €2,604 | +€2,604 | |
| Taxes | 450/3 | - | €2,604 | +€2,604 | |
| Other amounts payable | 47/48 | €730,206 | €1,239,290 | +€509,084 | +69.7% |
| Accrued charges and deferred income | 492/3 | €12,175 | €24,071 | +€11,896 | +97.7% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €17,113 | €41,534 | +€24,421 | +143% |
| Other operating charges | 640/8 | €3,412 | €3,666 | +€254 | +7.4% |
| Gross operating margin | 9900 | -€53,668 | €18,943 | +€72,611 | |
| Operating profit (loss) | 9901 | -€74,193 | -€26,257 | +€47,936 | +64.6% |
| Financial income | 75/76B | €10 | €26 | +€17 | +173% |
| Recurring financial income | 75 | €10 | €26 | +€17 | +173% |
| Financial charges | 65/66B | €31,057 | €58,429 | +€27,372 | +88.1% |
| Recurring financial charges | 65 | €31,057 | €58,429 | +€27,372 | +88.1% |
| Profit (loss) for the period before taxes | 9903 | -€105,240 | -€84,659 | +€20,581 | +19.6% |
| Profit (loss) for the period | 9904 | -€105,240 | -€84,659 | +€20,581 | +19.6% |
| Profit (loss) for the period to be appropriated | 9905 | -€105,240 | -€84,659 | +€20,581 | +19.6% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 15 October 2026 via checked.be.